Pierre Sabatier

Extracellular vesicle secretome from mesenchymal stromal cells prevents post-ischemic heart failure by targeting cardiac fibrosis

Grinnemo, Karl-Henrik; Braesch-Andersen, Ken; Wedin, Johan; Velica, Anna et al.

Ingår i Cell Stem Cell, s. 1324-1338, 2026

• DOI för Extracellular vesicle secretome from mesenchymal stromal cells prevents post-ischemic heart failure by targeting cardiac fibrosis
• Ladda ner fulltext (pdf) av Extracellular vesicle secretome from mesenchymal stromal cells prevents post-ischemic heart failure by targeting cardiac fibrosis

GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity

Motso, Aikaterini; Pelcman, Benjamin; Kalinovich, Anastasia; Kahlous, Nour Aldin et al.

Ingår i Cell, 2025

• DOI för GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity
• Ladda ner fulltext (pdf) av GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity

Extracellular vesicle secretome from mesenchymal stromal cells prevents post-ischemic heart failure by targeting cardiac fibrosis

Grinnemo, Karl-Henrik; Braesch-Andersen, Ken; Wedin, Johan; Velica, Anna et al.

Ingår i Cell Stem Cell, s. 1324-1338, 2026

• DOI för Extracellular vesicle secretome from mesenchymal stromal cells prevents post-ischemic heart failure by targeting cardiac fibrosis
• Ladda ner fulltext (pdf) av Extracellular vesicle secretome from mesenchymal stromal cells prevents post-ischemic heart failure by targeting cardiac fibrosis

GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity

Motso, Aikaterini; Pelcman, Benjamin; Kalinovich, Anastasia; Kahlous, Nour Aldin et al.

Ingår i Cell, 2025

• DOI för GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity
• Ladda ner fulltext (pdf) av GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity